← Open Payments lookup

VATSALA BHASKARAN: Open Payments

NPI 1427040401 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$504 in 22 payments from 9 companies in 2025. Trend: 2023 $418 · 2024 $462 · 2025 $504

Food & beverage: $504
CompanyPaymentsAmount
ABBVIE INC.12$196
Axsome Therapeutics, Inc.1$123
Neos Therapeutics, LP3$49
Neurocrine BioSciences, Inc.1$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
Janssen Pharmaceuticals, Inc1$23
E.R. Squibb & Sons, L.L.C.1$23
IDORSIA PHARMACEUTICALS US INC1$22
Collegium Pharmaceutical, Inc.1$15

Products named: VRAYLAR, Auvelity, Adzenys XR-ODT, INGREZZA, CAPLYTA, SPRAVATO, COBENFY, Quviviq.

Industry payments across TX — which companies pay providers there.